Sort
53,477 grants matching “addiction”
Medications Development for Drug Abuse Disorders
$472,726Eric C Strain · Johns Hopkins University · R01 · FY2008 · DA
National Infrastructure for Translating Addiction Research into Clinical Practice
$472,701Richard D Blondell · State University Of New York At Buffalo · R25 · FY2012 · AA
Mechanisms of interval timing
$472,590Michael A Crickmore · Boston Children'S Hospital · R01 · FY2022 · GM
Mechanisms of interval timing
$472,590Michael A Crickmore · Boston Children'S Hospital · R01 · FY2021 · GM
Mechanisms of interval timing
$472,590Michael A Crickmore · Boston Children'S Hospital · R01 · FY2020 · GM
NLRP inflammasome directed activation of the innate immune system produces synaptic damage in EcoHIV infected mice self-administering fentanyl
$472,588Norman J Haughey · Johns Hopkins University · R01 · FY2020 · DA
CBPR to Reduce Tobacco Smoking among Residents of a Low-Income Urgan Setting
$472,584Fernando A Wagner · Morgan State University · R24 · FY2012 · MD
Conformation-Selectivity Relations of Opioid Peptides
$472,583University Of Michigan At Ann Arbor · R01 · FY2005 · DA
Disruptions in the brain reward system through postnatal exposure to GABA agonists and anesthetics
$472,530Elif Engin · Mclean Hospital · R01 · FY2022 · HD
Administrative Core
$472,516Leslie Diane Leve · University Of Oregon · P50 · FY2021 · DA
X chromosome inactivation in sex disparities to substance use disorder
$472,500Steve Onyeka Oghumu · Ohio State University · DP1 · FY2022 · DA
X chromosome inactivation in sex disparities to substance use disorder
$472,500Steve Onyeka Oghumu · Ohio State University · DP1 · FY2025 · DA
X chromosome inactivation in sex disparities to substance use disorder
$472,500Steve Onyeka Oghumu · Ohio State University · DP1 · FY2021 · DA
X chromosome inactivation in sex disparities to substance use disorder
$472,500Steve Onyeka Oghumu · Ohio State University · DP1 · FY2024 · DA
Regulation of Striatal Signaling by RGS Proteins
$472,500Kirill A. Martemyanov · Scripps Florida · R01 · FY2014 · DA
Novel Platforms for Systematic Optical Control of Complex Neural Circuits In Vivo
$472,488Edward S. Boyden · Massachusetts Institute Of Technology · R01 · FY2012 · DA
The Dopamine Synapse and Associative Learning
$472,438David Sulzer · Columbia University Health Sciences · R01 · FY2024 · DA
Training Program: Drugs of abuse & Related Neuropeptides
$472,401Ellen M Unterwald · Temple Univ Of The Commonwealth · T32 · FY2006 · DA
Adherence to HIV Therapy in Heroin Addicts: Oral vs Extended Release Naltrexone
$472,397George E Woody · University Of Pennsylvania · R01 · FY2009 · DA
Expanding Treatment of Opioid Dependence Among the Privately Insured
$472,392Colleen L Barry · Yale University · R01 · FY2009 · DA
Delineating the Externalizing Construct &Its Facets
$472,385University Of Minnesota Twin Cities · R21 · FY2003 · MH
Antibody-based Therapy for Methamphetamine Abuse
$472,364S. Michael Owens · Univ Of Arkansas For Med Scis · R01 · FY2007 · DA
COUNSELING CONDITONS FOR THRICE WEEKLY BUP IN A PCC
$472,294Yale University · R01 · FY2000 · DA
Using Technology to Improve Clinical Counseling of Adolescent Risky Behaviors
$472,249Jennifer Salerno · Possibilities For Change, Llc · R44 · FY2018 · DA
Impact of new standards for tobacco products among dual e-cigarette/combusted cigarette users
$472,210Francis Joseph McClernon · Duke University · R01 · FY2019 · DA